Calian Group (TSE:CGY) Price Target Lowered to C$60.00 at Royal Bank of Canada

Calian Group (TSE:CGY - Get Free Report) had its price target dropped by equities researchers at Royal Bank of Canada from C$65.00 to C$60.00 in a research report issued to clients and investors on Tuesday,BayStreet.CA reports. The brokerage presently has an "outperform" rating on the stock. Royal Bank of Canada's price target points to a potential upside of 26.08% from the stock's current price.

Separately, CIBC reduced their price objective on shares of Calian Group from C$63.00 to C$62.00 in a research note on Friday, February 14th. Four analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Calian Group currently has a consensus rating of "Buy" and a consensus price target of C$68.83.

Calian Group Stock Performance

Calian Group stock traded up C$1.88 during mid-day trading on Tuesday, reaching C$47.59. The company's stock had a trading volume of 24,568 shares, compared to its average volume of 33,227. The company has a market capitalization of C$564.94 million, a P/E ratio of 50.96, a PEG ratio of 2.50 and a beta of 0.88. The firm's fifty day moving average price is C$43.28 and its two-hundred day moving average price is C$46.90. Calian Group has a 12-month low of C$39.41 and a 12-month high of C$59.27. The company has a debt-to-equity ratio of 39.54, a quick ratio of 1.20 and a current ratio of 1.29.

Insider Activity

In related news, Director Lori O'neill purchased 600 shares of the firm's stock in a transaction on Tuesday, February 18th. The shares were acquired at an average cost of C$44.75 per share, with a total value of C$26,850.00. Following the purchase, the director now directly owns 600 shares of the company's stock, valued at approximately C$26,850. This trade represents a ∞ increase in their ownership of the stock. 0.63% of the stock is owned by corporate insiders.

Calian Group Company Profile

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.